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A B S T R A C T
Objectives: This study aimed to investigate proteinuria occurring during dengue disease in children and
assess if measurement of this parameter can help physicians in the clinical management of patients.
Methods: Proteinuria was assessed by dipstick and quantified by urine protein:creatinine ratio (UPCR) in
samples from patients hospitalized with a confirmed dengue infection and in healthy controls.
Results: The dipstick tested positive in 42.9% of the patients presenting at hospital with dengue versus
20.0% in healthy controls. UPCR increased during the critical phase of the disease; peaking one week after
fever onset then decreasing as the patients recovered. Patients with warnings signs or severe dengue
were more likely to present with proteinuria detected by UPCR at the time of hospital admission
compared to patients without warning signs. The sensitivity of this marker, however, was limited as only
16.1% of the patients with warning signs had proteinuria.
Conclusions: Urine dipstick and UPCR do not seem to be very valuable for the triage of the patients at the
time of the initial consultation but the observation of a decrease of the UPCR during the course of the
illness appears to indicate an evolution towards recovery.
© 2017 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Dengue is the most prevalent mosquito-borne viral disease
worldwide.1 A majority of the infections are asymptomatic or
result in a mild febrile illness, but the dengue virus (DENV) is also
capable of producing a life-threatening disease. The main form of
severe dengue is characterized by plasma leakage with or without
bleeding, which may lead to circulatory collapse, called dengue
shock syndrome. The course of dengue illness can be divided into
three main phases: the febrile phase, the critical phase and the
recovery phase. Severe clinical disease manifestations occur during
the critical phase which begins around day 4–7 after the onset of
fever and lasts usually 48–72 hours. During the critical phase, the* Corresponding author at: GlaxoSmithKline, Vaccines R&D, Scientific Affairs and
Public Health, Singapore.
E-mail addresses: philippe.x.buchy@gsk.com, buchyphilippe@hotmail.com
(P. Buchy).
http://dx.doi.org/10.1016/j.ijid.2016.12.022
1201-9712/© 2017 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).condition of patients can improve or worsen rapidly; requiring
careful monitoring by care givers. Early clinical management based
on fluid replacement therapy reduces the morbidity and mortality
associated with severe dengue.2
The major obstacle for an effective clinical management of
dengue is the inability to accurately predict, at an early stage of
infection, which patients are likely to develop a severe form of the
disease. There is a need for simple, effective and cheap tests to
identify patients at risk and guide triage. Wills et al. observed an
increase of urinary protein clearance due to the increase in
systemic vascular permeability that occurs in severe dengue.
Subsequently, it has been proposed that a simple urine protein
excretion screening test could be indicative of the severe form of
dengue and therefore guide the triage and monitoring of the
patients with suspected dengue infection.3
The objective of this study was to investigate the presence of
proteinuria during dengue disease in children by simple urinalysis
strip and by protein:creatinine ratio (UPCR) and assess if these
parameters can help the physicians to improve the clinicalciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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associated proteinuria profiles, a urinary protein electrophoresis
was performed in a subset of the hospitalized patients.
Methods
Clinical samples
A total of 241 spot urine samples obtained from 108 patients
with laboratory-confirmed dengue virus infection (DVI) were
randomly selected among samples obtained in 2013 during the
DENgue research Framework for Resisting Epidemics in Europe
(DENFREE) study. A confirmed dengue case was defined by the
detection of viral RNA by RT-PCR and/or the detection of the
NS1 protein and/or an IgM seroconversion and/or a four-fold
antibody titer increase measured by hemagglutination inhibi-
tion assay (HIA) in paired plasma of patients presenting with
symptoms suggestive of DVI. Most urine samples (225/241) were
collected during hospitalization 1–11 days after the onset of
fever. An additional 16 samples were collected one or three
months after discharge from hospital. Patients were categorized
as experiencing dengue “with” or “without” warning signs
(WS+ or WS-, respectively) or severe dengue based on the
2009 case definitions established by the World Health Organi-
zation (WHO).2 The immune status of patients (primary or
secondary infection) was determined by HIA according to WHO
criteria.4
A further 15 samples collected from healthy children recruited
during a community-based study were also added to the panel.
These controls were household members of some of the patients
identified during the DENFREE hospital-based study that had no
biological evidence of DVI (RT-PCR negative, NS1 negative, no anti-
DENV IgM or increasing IgG titer).
Ethical statement
The DENFREE project was approved by the Cambodian National
Ethics Committee for Health Research (authorization no.
063NECHR). The children’s legal representatives signed a written
consent before the enrolment of the patient.
Urine analysis
The presence of protein in urine collected at the time of patient
admission at hospital was checked using semi-quantitative
Mission urine dipsticks (Acon, San Diego, USA). The test was
performed according to the manufacturer’s instructions. Results
were graded as: no protein; 150 mg/L (trace); 300 mg/L; 1000 mg/L;
3000 mg/L; and 20,000 mg/L. Presence of protein at any
concentration was considered as a positive result. UPCRs were
measured in samples collected during the course of hospitaliza-
tion using a Cobas integra 400 plus analyzer (Roche Diagnostics,
Germany). Proteinuria was defined as a UPCR 45 mg/mmol.5
Urine protein electrophoresis (UPEP) was performed with a
MINICAP capillary electrophoresis platform (Sebia, France).
Following the manufacturer’s instructions, only samples with a
total protein concentration >100 mg/L were tested.
Statistical analysis
Statistical tests were performed using STATA version 11.0
(StataCorp, USA). The statistical differences between categorical
groups were detected using the Fisher’s exact test. The Kruskal-
Wallis rank test and the Mann Whitney U test were used for
continuous independent variables and the Wilcoxon test was used
for continuous dependant variables. The correlation between twocontinuous variables was assessed by Spearman’s rank correlation
test.
A Generalized Additive Mixed Model (GAMM) was used to
evaluate factors independently associated with the UPCR values
and with the occurrence of proteinuria. Five explanatory variables
were included in the model: age, gender, sampling day after onset
of fever (daof), immune status (primary or secondary infection)
and 2009 WHO disease classification (dengue without warning
signs, dengue with warning signs, severe dengue). A GAMM was
used because a non-linear relationship between the response
variables (UPCR or proteinuria occurrence) and both “daof” and
“age” explanatory variables was expected. A mixed model was
used with patient ID as a random effect explanatory variable to
take into account the non-independence of samples collected from
the same patients and potential random individual variations
between patients. The analysis was performed using the “gamm4”
package (version 0.2-3) under the R statistical environment
(R Foundation, Vienna, Austria).
Significance was assigned at p < 0.050.
Results
A total of 108 patients were included in this study. A summary
of the patients’ characteristics, clinical and virologic data is
presented in Table 1.
Protein detection by dipstick in urine specimens collected at admission
A total of 39 patients (42.9%) tested positive for proteinuria by
dipstick at the time of admission to the hospital (Table 2). Most
positive samples (71.8%, 28/39) only contained traces of protein
(150 mg/L) while nine and two patients had an approximate
protein concentration of 300 mg/L and 1000 mg/L, respectively. A
positive dipstick result was observed for 38.1% (8/21) and 32% (16/
50) of the patients admitted at hospital for a dengue WS- and WS+,
respectively (Fisher’s exact P = 0.784). Proteins were detected in
the urine sample of 75% (15/20) of the patients presenting with a
severe dengue. Three urine samples of the control group (20%, 3/
15) contained traces of protein. The prevalence of proteinuria in
dengue patients WS- and WS+ was not significantly different from
the one obtained for the control group (P = 0.295 and 0.522,
respectively). When considering the immune status of the
patients, 53.2% (25/47) of those with a secondary infection and
26.9% (7/26) of the patients with a primary infection had
proteinuria (P = 0.048).
Proteinuria determined by the UPCR during the course of
hospitalization
The UPCR was tested at admission in 52 patients (median
daof = 4, IQR = [3–4]) and proteinuria was detected in 23.1% (n = 12)
of the cases. None of the WS- dengue cases had proteinuria
compared with 16.1% (5/31) in WS+ cases and 50% (7/14) in
patients experiencing severe dengue (Table 3). The prevalence of
proteinuria at admission was not significantly different between
primary and secondary dengue infections (13.6% vs 28.6%,
P = 0.281) (Table 3).
The UPCR was measured in 178 urine samples collected during
the course of hospitalization from nine WS- patients, 43 WS+
patients and 17 patients with a severe dengue. Nine samples were
excluded from the analysis due to very low creatinine concentra-
tion (<1 mmol/L) that resulted in an overestimation of the UPCR.
Proteinuria was observed in 33.3% and 23.3% of the WS- and WS+
patients, respectively, and 47.1% of the patients with severe
dengue, (Table 3). Differences between the three groups of patients
were not statistically significant. A total of 26.1% of the primary
Table 1
Summary of demographic, clinical and virologic information of the patients.
Dengue without warning signs Dengue with warning signs Severe dengue
Number of patients (number of samples) 24 (45) 62 (143) 22 (53)
Median age in years [iqr] 7 [6–12] 8.5 [7–12] 9 [7–11]
Sex (Male) 15 (62.5%) 37 (59.7%) 15 (68.2%)
Median day of fever at hospital admission [iqr] 2 [2–3] 4 [3–4] 4 [4–5]
Median length of stay at hospital [iqr] 5 [5–5.5] 5 [4–6] 5 [4–5]
Dengue diagnostic
RT-PCR and NS1 positive 19 (79.2%) 46 (74.2%) 9 (40.9%)
RT-PCR positive and NS1 negative 5 (20.8%) 11 (17.7%) 8 (36.4%)
RT-PCR negative and NS1 positive 0 (0%) 3 (4.8%) 1 (4.5%)
Othera 0 (0%) 2 (3.2%) 4 (18.2%)
Immune status
Primary infection 10 (41.7%) 20 (32.2%) 0 (0%)
Secondary infection 11 (45.8%) 32 (51.6%) 21 (95.5%)
Undeterminedb 3 (12.5%) 10 (16.1%) 1 (4.5%)
Clinical manifestations at admission
Dry bleedingc 4 (16.7%) 15 (24.2%) 6 (27.3%)
Wet bleedingd 1 (4.2%) 10 (16.1%) 7 (31.8%)
Abdominal pain 0 (0%) 52 (83.9%) 22 (100%)
Persistent vomiting 0 (0%) 39 (62.9%) 22 (100%)
Lethargy/restlessness 1 (4.2%) 19 (30.6%) 15 (68.2%)
Hepatomegaly 0 (0%) 29 (46.8%) 15 (68.2%)
Ascites 0 (0%) 15 (24.2%) 8 (36.4%)
Pleural effusion 0 (0%) 12 (19.4%) 6 (27.3%)
Facial edema 0 (0%) 2 (3.2%) 3 (13.6%)
Cold extremities 0 (0%) 1 (1.6%) 19 (86.4%)
Cyanosis 0 (0%) 0 (0%) 11 (50%)
Hypotension, weak or undetectable pulse 0 (0%) 0 (0%) 12 (50.5%)
Narrow pulse pressure 0 (0%) 0 (0%) 16 (72.7%)
Delayed capillary refill time 0 (0%) 0 (0%) 14 (63.6%)
iqr: interquartile range.
a IgM seroconversion in paired plasma and/or fourfold increase of the antibody titer measured by hemagglutination inhibition assay (HIA) in paired plasma.
b Immune status is undetermined when the interval between admission and hospital discharge is <7 days and the HI titer at the time of hospital discharge is 2560.
c Petechiae, purpura and/or ecchymosis.
d Nose, gums bleeding, hematemasis, melena and/or conjunctival hemorrhage.
40 A.-C. Andries et al. / International Journal of Infectious Diseases 55 (2017) 38–44dengue cases and 33.3% of the secondary cases experienced at least
one episode of proteinuria during hospitalization (P = 0.768).
Proteinuria was more often detected between day 5 and day 7 after
onset of fever when UPCR values were the highest (Figure 1). None
of the controls had a UPCR 45 mg/mmol.
Sixteen patients included in the study were tested for UPCR one
(n = 4) or three (n = 12) months after discharge from hospital. None
had a UPCR 45 mg/mmol.
UPCRs according to the day of sampling after the onset of fever
are shown in Figure 1. No significant difference was observed in
UPCRs between the different groups of patients. UPCRs were
significantly higher in each category of dengue patients at each
time-point compared to controls.Table 2
Results of urinary protein dipstick test performed at the time of admission to hospital
Positive dipstick, total Positive dipstick
Control (n = 15) 3 (20.0%) 3 (20.0%) 
Total dengue (n = 91) 39 (42.9%) 28 (30.8%) 
2009 WHO dengue classification
Dengue without warning signs (n = 21) 8 (38.1%) 6 (28.6%) 
Dengue with warning signs (n = 50) 16 (32.0%) 12 (24.0%) 
Severe dengue (n = 20) 15 (75.0%) 10 (50.0%) 
Immune status
Primary infection (n = 26) 7 (26.9%) 7 (26.9%) 
Secondary infection (n = 47) 25 (53.2%) 16 (34.0%) 
Undetermineda (n = 18) 7 (38.9%) 5 (27.8%) 
a Immune status is undetermined when the interval between admission and hospitaModeling factors independently associated with UPCR values in
dengue cases
The “daof” variable and the age of the patient had a significant
effect on UPCRs (P < 0.001) (Table 4). The GAMM-estimated
relationships between UPCR and both “age” and “daof” variables
are shown in Figure 2. The model predicted higher UPCR in urine
samples collected from older children (13 years) and between
DAOF 6–8. The immune status of the patient had no effect on UPCR
values. A binomial GAMM was also used to assess factors
independently associated with the occurrence of proteinuria in
dengue patients, using the same variables. No significant associa-
tion was found (Supplementary file 2)..
, 150 mg/L (trace) Positive dipstick, 300 mg/L Positive dipstick, 1000 mg/L
0 (0.0%) 0 (0.0%)
9 (9.9%) 2 (2.2%)
2 (9.5%) 0 (0.0%)
4 (8.0%) 0 (0.0%)
3 (15.0%) 2 (10.0%)
0 (0.0%) 0 (0.0%)
7 (14.9%) 2 (4.3%)
2 (11.1%) 0 (0.0%)
l discharge is <7 days and the HI titer at the time of hospital discharge is 2560.
Table 3
UPCRs in samples collected at the time of admission and during the course of hospitalization.
Total
dengue
2009 WHO disease classification Immune status
Dengue without
warning signs
Dengue with
warning signs
Severe
dengue
Primary
infection
Secondary
infection
Undetermineda
Hospital admission
Number of patients tested 52 7 31 14 22 21 9
Number of patients with an UPCR  45 mg/mmol 12
(23.1%)
0 (0.0%) 5 (16.1%) 7 (50.0%) 3 (13.6%) 6 (28.6%) 3 (33.3%)
All samples (admission and during hospitalization)
Number of patients included 69 9 43 17 23 33 13
Number of patients with an UPCR  45 mg/mmol in
at least one sample
21
(30.4%)
3 (33.3%) 10 (23.3%) 8 (47.1%) 6 (26.1%) 11 (33.3%) 4 (30.8%)
Median UPCR (mg/mmol) [irq] 30.0
[22.1-
42.2]
30.8
[20.5-43.0]
28.5
[21.6-38.5]
34.3
[25.7-
48.8]
29.6 [22.1-
43.3]
29.3 [21.6-
48.8]
33.1 [23.6-
40.9]
Median day of illness when UPCR  45 mg/mmol
[irq]
6 [5–7] 6 [5–6.5] 6 [4–7] 6 [5–7] 5.5 [4–6.5] 6 [4–8] 6 [5–7]
UPCR: Urine protein:creatinine ratio.
iqr: interquartile range.
a Immune status is undetermined when the interval between admission and hospital discharge is <7 days and the HI titer at the time of hospital discharge is 2560.
Figure 1. UPCR according to time of sampling and disease severity.
Horizontal solid lines represent the median value measured in control patients. Horizontal dash lines represent the quartiles. UPCR: Urine protein:creatinine ratio, DAOF: Day
After Onset of Fever, WS-: dengue without Warning signs, WS+: dengue with Warning signs, SD: Severe dengue
Table 4
Effects of age, gender, disease classification, immune status and day of disease on
UPCR.
Linear terms Estimate p-value
Male reference
Female 0.141 0.454
dengue WS- reference
dengue WS+ 0.146 0.604
severe dengue 0.269 0.417
primary dengue reference
secondary dengue 0.029 0.899
Non linear terms edf p-value
s(daof) 4.921 < 0.001
s(age) 3.414 < 0.001
edf: effective degrees of freedom of the smooth function terms (edf >1 indicate
nonlinear relationships).
F value is an approximate F-test.
daof: day after onset of fever.
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Serum total protein levels and UPCRs were assessed in parallel
in 51 dengue patients. UPCRs tended to be higher in patients with
hypoproteinemia (median = 31.6 mg/mmol, IQR = [22.1–48.9])
compared to patients with a normal serum protein concentration
(median = 25.9 mg/mmol, IQR = [18.3–32.1]) but the difference was
not significant (P = 0.096). A total of 38.1% (8/21) of the patients
with hypoproteinemia had a UPCR 45 mg/mmol, whereas 10% (3/
30) of the patients with a normal total protein concentration
presented such a significant proteinuria (P = 0.035).
Urine protein electrophoresis
UPEP was performed on 27 admission samples in which the
total protein concentration was 100 mg/L. Results are presented
in Table 5.
Figure 2. Relationship between UPCR and day of sampling after fever onset (A) or
patient age (B).
A GAMM-model was used to estimate the relationship. The figure in the y-axis is the
effective degrees of freedom of the smooth function terms. daof: day after onset of
fever
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Increased urinary excretion of protein in patients infected by
DENV is thought to be a hallmark of vascular endothelial cells
defect and plasma leakage associated with complicated forms of
dengue and is considered a possible prognostic marker.3 Protein-
uria has been reported in up to 74% of patients with dengue
hemorrhagic fever (DHF)6 and cases of self-limiting nephrotic-
range proteinuria in patients with DHF presenting no manifes-
tations of renal damage have been described elsewhere.7,8 The
mechanism underlying the hypothesis of increased protein
excretion in urine is that during DVI the glycocalyx of the
endothelial cells is disrupted either by direct action of the virus or
by the NS1 antigen,3,9,10 causing plasma leakage. At the kidney
level, alteration of the glycocalyx layer that coats the glomerular
endothelial cells enables the passage of macromolecules in the
primary urine. In normal conditions, this passage is restricted in
order to maintain the intravascular albumin concentration. As
macromolecules cannot be reabsorbed by tubules, a glomerular
proteinuria, mainly characterized by the presence of albumin in
the final urine, occurs. Increased clearance of proteins in urine due
to disruption of the glycocalyx has been described during diabetes
mellitus,11 childhood nephrotic syndrome12 and meningococcal
septicemia.13Table 5
Urine protein electrophoresis profiles in dengue patients.
Pattern Number of observation 
Total
(n = 27)
WS-
(n = 2)
Pattern 1: Normal 3 (11.1%) 0 (0.0%) 
Pattern 2: Alpha-1/Alpha-2 14 (51.9%) 2 (100%) 
Pattern 3: Albumin 6 (22.2%) 0 (0.0%) 
Pattern 4: “Serum-like” 4 (14.8%) 0 (0.0%) 
UPCR: Urine protein:creatinine ratio.
WS-: Without warning signs; WS+: With warning signs; SD: Severe Dengue.We first investigated the presence of proteinuria by using a
dipstick, one of the easiest and cheapest methods for the detection
of proteins in urine. We observed that urinary dipstick used on
samples collected at the time of initial medical consultation before
admission to the hospital was not a reliable tool for the triage of
dengue patients. The proportions of positive tests in controls (20%)
and in dengue WS- (38.1%) and WS+ (32%) were not statistically
different. Similar results were obtained when the patients were
classified according to the 1997 WHO guidelines (data not shown).
Vasanwala et al. and Lumpaopong et al. also assessed the
prognostic value of urine dipstick and demonstrated that this
rapid test was not able to discriminate between dengue fever
(DF) and DHF.14,15 In the present study, the comparison of the
dipstick results with the UPCR results indicated that only 43.5%
of the patients who tested positive for proteinuria by dipstick
had a proteinuria considered as significant as defined by a UPCR
45 mg/mmol (data not shown). A proteinuria detected by dipstick
and associated with a UPCR <45 mg/mmol was probably minor
and/or the result of a urine concentration associated with a mild
dehydration caused by fever or vomiting as previously reported.16
The UPCR is actually a better tool to assess the proteinuria than
simple dipstick as it intends to adjust for fluctuations in fluid intake
and hydration status.
The gold standard to determine the proteinuria is provided
by the measurement of total protein or albumin in urine over a
24-hour period (timed urine). However, this method is time-
consuming and cumbersome. Measurement of urine albumin:
creatinine or protein:creatinine ratios in random spot urine
samples has been demonstrated to be an acceptable alternative
to timed urine samples.17,18 Since it was already demonstrated that
urine albumin:creatinine ratios in dengue patients were not useful
tools to predict the evolution towards severe dengue and the need
for hospitalization,19 we instead evaluated the potential value of
the UPCR which was previously investigated in adults but not in
children.14 Using a more conservative definition of 45 mg/mmol as
recommended by the Royal College of Physicians of London5,20 we
demonstrated that patients with WS+ and severe dengue were
more likely to have an elevated UPCR at the time of hospital
admission compared to WS- patients. Nevertheless, the sensitivity
of this marker was limited as only 16.1% of the patients WS+ had
such significant proteinuria.
Our multivariate analysis of UPCR during the course of the
disease indicated that this ratio was significantly higher six to eight
days after the onset of fever which is in agreement with previous
reports.14,19,21 Rather than being a marker that could be used for
patient triage at the time of first medical consultation, UPCR
measurement seems to be more useful for monitoring patients
during the course of the disease. Indeed, the peak UPCR usually
occurred at the end of the critical phase of the disease and the
decrease in the ratio seemed to correspond with the beginning of
the recovery phase.
Hypoproteinemia in dengue cases usually indicates a plasma
leakage.4 Here we observed that significant proteinuria was moreMean UPCR
WS+
(n = 13)
SD
(n = 12)
2 (15.3%) 1 (8.3%) 27.3 (min = 17.; max = 33.10)
7 (53.8%) 5 (41.7%) 38.8 (min = 18.5; max = 73.5)
2 (15.3%) 4 (33.3%) 85.2 (min = 27.7; max = 130.2)
2 (15.3%) 2 (16.7%) 298.12 (min = 114.5; max = 664.4)
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mmol was observed in only 38.1% of the patients with hypo-
proteinemia. These results may suggest that the plasma leakage
does not necessarily always cause significant proteinuria or that it
is quickly compensated.
Three main categories of proteinuria can be distinguished by
UPEP: overflow proteinuria, tubular proteinuria and glomerular
proteinuria.23 Overflow proteinuria is a pre-renal proteinuria
characterized by an abnormal peak of one of the five protein
fractions. UPEP in tubular proteinuria demonstrates alpha and/or
beta globulin peaks, with or without a minor fraction of albumin.
UPEP analysis of glomerular proteinuria shows either a dominant
albumin fraction in selective glomerular proteinuria or a pattern
similar to serum proteins in non-selective glomerular proteinuria.
We did not observe any case of overflow proteinuria in the limited
number of cases included in our study. Patterns compatible with a
tubular proteinuria, a selective glomerular proteinuria and a non-
selective glomerular proteinuria, were observed in 51.9%, 22.2%
and 14.8% of the samples tested by UPEP, respectively. The
glomerular proteinuria was associated with a high value of UPCR
and we showed in this study that a UPCR 75 mg/mmol was 100%
specific of a glomerular proteinuria. If we set a value of 75 mg/
mmol for the UPCR as a hallmark of a glomerular proteinuria,
12 patients beyond the 21 that experienced a significant
proteinuria could have been classified in that group. Among those
12 patients, one was classified as dengue without warning signs,
six as dengue with warning signs and five as severe dengue. The
hypothesis that the proteinuria in dengue disease was solely the
result of disruption of the glycocalyx can only be partially true as
we detected both tubular and glomerular proteinuria cases in
almost the same proportions. Renal impairments associated to
both glomerular and tubular syndromes have already been
described.6 Kidney biopsies from patients with dengue of varying
degrees of severity revealed acute tubular necrosis resulting in
tubular impairments.24–28 Ischemic processes, which are common
in patients with severe hypovolemic shock, have been suggested as
an explanation to tubular necrosis in DSS patients.25 Interstitial
edema and mononuclear infiltration can also contribute to tubular
necrosis in patients without shock syndrome.24,27
A limitation of our study was the small number of patients
without warning signs as clinical specimens were only collected
from hospitalized children and not from ambulatory cases. This
resulted in an underrepresentation of the mildest form of dengue
disease and may explain why we did not observe differences in
proteinuria between patients with or without warning signs.
Another limitation was the absence of daily UPCR measurement for
each patient: the median number of samples tested for each
patient was only two for a median length of hospitalization of five
days. It is therefore possible that the occurrence of more significant
proteinuria episodes were not captured in some patients. Another
limitation of the study is that we were not able to explore potential
confounding factors as number of other etiology of proteinuria do
exist, including primary viral infections that are not uncommon in
children (e.g., adenovirus, cytomegolavirus, Epstein-Barr virus,
enterovirus, etc.).
The kidney is one of the major organs affected during dengue
but the mechanism and the prevalence of renal involvement in
children with dengue fever remains unclear. Renal function is not
routinely assessed in patients hospitalized for suspected or
confirmed dengue and thus the impact of dengue infection on
the kidneys could well be under-recognized. This is a third
limitation of our study as the proteinuria was measured
retrospectively and the renal function was not assessed by the
clinicians. There is a clear need, for a future study, to assess
simultaneously the various parameters associated with a renal
dysfunction as the hematuria, the proteinuria, an electrolytedisturbance, the glomerular filtration rate, and eventually to
conduct renal biopsies. In conclusion, this study indicates that
protein excretion in urine, estimated by UPCR, increases during the
course of dengue disease to reach a maximum level approximately
one week after the onset of fever. We found that neither urine
dipstick nor UPCR measurement were useful for patient triage at
the time of first visit to hospital. Monitoring the urinary protein
excretion during the course of the disease, however, might be a
factor indicating the evolution towards disease recovery.
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